1. At a Glance
Elitecon is that kid in class who didn’t study all year, failed multiple tests, then suddenly topped with 99% in the finals. For years, it reported no revenue and net worth erosion. Suddenly in FY24–25, the company starts reporting ₹500+ Cr quarterly sales and ₹70 Cr profits. The market cap? ₹50,000+ Cr—almost equal to Godfrey Phillips, despite Elitecon’s brands sounding like college canteen specials: “Yummy Filter Khaini” and “Gurh Gurh.” P/E of 724 suggests investors are smoking something stronger than Elitecon’s products.
2. Introduction
Elitecon International is a tobacco business that went from obscurity to market darling faster than you can say “rights issue.” For years, this company was basically a BSE-listed zombie—no revenues, accumulated losses, and promoters bailing it out. Then, out of nowhere, in FY24 it starts reporting hundreds of crores in sales, acquiring food and cryogenic subsidiaries, setting up UAE subsidiaries, and issuing convertible warrants worth ₹158 Cr.
Think of it as the Bollywood reboot of a forgotten 80s film—new cast, new storyline, but you’re still not sure if the script holds.
The business is tobacco and allied products: cigarettes (brand:Inhale—subtle), sheesha (Al Noor), khaini (Yummy Filter Khaini), and smoking mixtures (Gurh Gurh). Expansion plans include matchboxes and pipes—because if you’re going old-school, why not go full Sherlock Holmes?
But the real story is not tobacco. It’s valuation wizardry. With a book value of ₹1, the stock trades at ₹316. Market cap: ₹50,000 Cr. EV/EBITDA: 704x. Price-to-sales: 92x. In other words, investors aren’t valuing cigarettes here—they’re valuing vibes.
3. Business Model (WTF Do They Even Do?)
The core is tobacco manufacturing and exports:
- Cigarettes– BrandInhale(because “Die Slowly” was taken).
- Sheesha/Hookah– BrandAl Noor, targeting Gulf markets.
- Chewing & Pouch Tobacco– Khaini, zarda, flavored molasses tobacco.
- Other Products– Pipes, matches, grinders—basically anything that burns.
International footprint includes UAE, Singapore, Hong Kong, and Europe. Clearly, someone figured out that tobacco demand is recession-proof (and regulation-resistant in certain geographies).
Twist in the tale:In FY24, the company acquired
Pandokhar Food LLPandGolden Cryo Pvt Ltd. So now, Elitecon is into food and cryogenics—because why limit yourself to killing lungs when you can also freeze people and feed them?
4. Financials Overview
| Metric | Jun 2025 (Latest Qtr) | Mar 2025 (Prev Qtr) | YoY (Jun 2024) | QoQ % | YoY % |
|---|---|---|---|---|---|
| Revenue (₹ Cr) | 525 | 313 | 94 | +68% | +458% |
| EBITDA (₹ Cr) | 73 | 43 | 13 | +70% | +462% |
| PAT (₹ Cr) | 72.1 | 43 | 13 | +68% | +455% |
| EPS (₹) | 0.45 | 0.27 | 0.08 | +67% | +462% |
Commentary:From a literal zero company in 2015–2016 to ₹500+ Cr per quarter in 2025—this is the Lazarus story of Indian markets. Problem is, at 724x P/E, even God couldn’t justify this pricing.
5. Valuation (Fair Value RANGE Only)
- P/E Method: EPS (TTM) ≈ ₹0.44. Apply industry P/E (32.8x) → FV ≈ ₹15.
- EV/EBITDA: EV ≈ ₹50,433 Cr, EBITDA ≈ ₹69 Cr → EV/EBITDA ≈ 730x. Fair range using industry avg (20x) → FV ≈ ₹1,500 Cr MCap → ~₹9/share.
- DCF: Assuming ₹550 Cr sales, 12% OPM, 15% growth, discount 12% → FV ~₹20–₹30/share.
👉Final FV Range: ₹9 – ₹30/share (Educational Only). CMP ₹316 is pure smoke premium.
6. What’s Cooking – News, Triggers, Drama
- Fundraise: Issued 15.85 Cr convertible warrants (₹158 Cr). Promoter loans converted into securities. This is textbook dilution disguised as “growth.”
- Acquisitions: Bought food and cryogenics businesses
